Sparrow Pharmaceuticals

Targeted cardiometabolic therapeutics

Portland, United States · Founded 2021 · $217.0M raised

Headquarters
Portland, Oregon
Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$217.0M
Last Round
$95.0M Series BSep 2025
Rounds
4

About

Leveraging scientific insights into the intracellular regulation of cortisol, Sparrow is pioneering a precision approach to cardiometabolic disease. Their lead candidate, clofutriben, is a highly potent HSD-1 inhibitor designed to reduce elevated intracellular cortisol, addressing impaired glucose control in millions of patients with difficult-to-control type 2 diabetes.

Summary

Sparrow Pharmaceuticals is a Biotech company based in Portland, United States, founded in 2021. It has raised $217.0M in total across 4 rounds, most recently a $95.0M Series B round in Sep 2025. Investors include OrbiMed, RA Capital Management and Forbion Capital Partners.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2025
$95.0M

Sign up to see all 4 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sparrow Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/sparrow-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/sparrow-pharmaceuticals" alt="Sparrow Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>